Skip to main content
logo
Enorama Pharma AB (publ) (STO:ERMA)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.240
+0.848 (216.33%)
Aug 14, 2026, 5:29 PM CET

Enorama Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9214220311428171
Market Cap Growth
-52.66%-29.89%77.51%308.04%-83.60%-12.51%
Enterprise Value
7513619410827171
Last Close Price
1.241.913.362.512.9517.98

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
42.3952.0112.8984.294.1013.36
PB Ratio
-2.52-6.0726.045.860.898.01
P/TBV Ratio
--26.045.860.898.01

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
34.2549.6212.3079.673.8813.39

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
---0.020.060.18
Net Debt / Equity Ratio
0.490.13-0.27-0.29-0.07-0.39
Net Debt / EBITDA Ratio
0.310.050.040.140.050.32
Net Debt / FCF Ratio
0.390.050.060.140.070.28
Asset Turnover
0.080.230.630.030.140.28
Inventory Turnover
2.152.731.551.483.666.03
Quick Ratio
0.550.180.430.800.681.77
Current Ratio
0.640.251.871.270.951.92
Return on Equity (ROE)
---320.44%-174.74%-158.97%-239.87%
Return on Assets (ROA)
-124.14%-321.44%-118.33%-62.91%-52.64%-37.20%
Return on Capital Employed (ROCE)
466.80%264.90%-610.00%-173.10%-115.60%-69.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-70.57%-52.74%-21.56%-38.97%-149.82%-16.22%
FCF Yield
-48.94%-41.60%-17.57%-36.12%-117.48%-17.67%
Buyback Yield / Dilution
-26.99%-30.99%-91.50%-253.96%-26.23%-11.44%